References in this report (the "Quarterly Report") to "we," "us" or the
"Company" refer to BOA Acquisition Corp. References to our "management" or our
"management team" refer to our officers and directors, references to the
"Sponsor" refer to Bet on America LLC. The following discussion and analysis of
the Company's financial condition and results of operations should be read in
conjunction with the financial statements and the notes thereto contained
elsewhere in this Quarterly Report. Certain information contained in the
discussion and analysis set forth below includes forward-looking statements that
involve risks and uncertainties.

Special Note Regarding Forward-Looking Statements



This Quarterly Report includes "forward-looking statements" that are not
historical facts, and involve risks and uncertainties that could cause actual
results to differ materially from those expected and projected. All statements,
other than statements of historical fact included in this Quarterly Report
including, without limitation, statements in this "Management's Discussion and
Analysis of Financial Condition and Results of Operations" regarding the
Company's financial position, business strategy and the plans and objectives of
management for future operations, are forward-looking statements. Words such as
"expect," "believe," "anticipate," "intend," "estimate," "seek" and variations
and similar words and expressions are intended to identify such forward-looking
statements. Such forward-looking statements relate to future events or future
performance, but reflect management's current beliefs, based on information
currently available. A number of factors could cause actual events, performance
or results to differ materially from the events, performance and results
discussed in the forward-looking statements. For information identifying
important factors that could cause actual results to differ materially from
those anticipated in the forward-looking statements, please refer to the Risk
Factors section of the Company's 2021 Form 10-K filed with the U.S. Securities
and Exchange Commission (the "SEC"). The Company's securities filings can be
accessed on the EDGAR section of the SEC's website at www.sec.gov. Except as
expressly required by applicable securities law, the Company disclaims any
intention or obligation to update or revise any forward-looking statements
whether as a result of new information, future events or otherwise.

Overview



We are a blank check company incorporated as a Delaware corporation on October
26, 2021. Our business purpose is to effect a merger, capital stock exchange,
asset acquisition, stock purchase, reorganization or similar business
combination with one or more businesses, which we refer to throughout this
Quarterly Report as our initial business combination. On February 26, 2021, we
consummated an initial public offering.

Recent Developments

Proposed Business Combination



Under the Business Combination Agreement, immediately prior to the Effective
Time, (a) each outstanding series A voting ordinary share of $0.01 each in the
capital of Selina, outstanding series B voting ordinary share of $0.01 each in
the capital of Selina, and outstanding series C voting ordinary share of $0.01
each in the capital of Selina (each, a "Selina Preferred Share") shall become
and be redesignated as a Selina Ordinary Share in accordance with the governing
documents of Selina (the "Selina Preferred Share Redesignation"); (b) Selina's
convertible loan notes, the put and call options, the term loan, the 2018
warrant instruments, and the 2020 warrant instrument (collectively, the "Selina
Convertible Instruments") may be converted into Selina Ordinary Shares in
accordance with the terms of the Selina Convertible Instruments and the terms of
the Business Combination Agreement (the "Selina Convertible Instrument
Conversion"); and (c) immediately following the Selina Preferred Share
Redesignation and the Selina Convertible Instrument Conversion, Selina shall
effect a share subdivision, whereby each Selina Ordinary Share will be
subdivided into such number of Selina Ordinary Shares calculated in accordance
with Section 2.1(c) of the Business Combination Agreement to cause the value of
the outstanding Selina Ordinary Shares immediately prior to the Effective Time
to equal $10.00 per share (the "Share Subdivision" and, together with the Selina
Preferred Share Redesignation and the Selina Convertible Instrument Conversion,
the "Capital Restructuring").

In addition, immediately prior to the Effective Time, (i) each issued and
outstanding share of our Class B common stock, will be automatically converted
into one (1) share of our Class A common stock in accordance with the terms of
our Charter (such conversion, the "Class B Conversion"), (ii) in accordance with
and as required by the Charter, we will provide an opportunity for our
stockholders

                                       22

  Table of Contents

to redeem all or a portion of their outstanding shares of Class A common stock
as set forth therein (the "Stockholder Redemption") and (iii) each issued and
outstanding Unit will be automatically separated and the holder thereof will be
deemed to hold one share of Class A common stock and one-third of one Public
Warrant (the "Unit Separation").

Pursuant to the Business Combination Agreement, after giving effect to the
Capital Restructuring, the Class B Conversion, Stockholder Redemption, and the
Unit Separation, at the Effective Time, (i) each issued and outstanding share of
our Class A common stock will automatically be converted into the right of the
holder thereof to receive one (1) Selina Ordinary Share and (ii) each Warrant
outstanding immediately prior to the Effective Time will automatically and
irrevocably be assumed by and assigned to Selina and converted into a
corresponding warrant to purchase a Selina Ordinary Share (each, a "Selina
Warrant").

Concurrently with and following the execution of the Business Combination
Agreement, the Company, Selina, and the PIPE Investors entered into a series of
subscription agreements (collectively, the "Subscription Agreements"), which
provide for the PIPE Investment, and (ii) Bet on America Holdings LLC, an
affiliate of our Sponsor in its capacity as one of the PIPE Investors, agreed to
a conditional backstop obligation for an additional commitment to purchase up to
an aggregate of 1,500,000 Selina Ordinary Shares at a price per share of $10.00
in the event that the cash proceeds condition in the Business Combination
Agreement is not satisfied at Closing. The closing of the PIPE Investment is
conditioned upon the consummation of the Business Combination.

Consummation of the transactions contemplated by the Business Combination
Agreement are subject to customary conditions of the respective parties,
including receipt of approval from our stockholders and Selina's shareholders
for consummation of the transactions and certain other actions related thereto
by our stockholders.

Other than as specifically discussed, this Quarterly Report does not assume the closing of the transactions contemplated by the Business Combination Agreement.

Note Subscription Agreements, Indenture and Amended and Restated Warrant Agreement



In connection with the Business Combination, on April 22, 2022, Selina entered
into convertible note subscription agreements (the "Note Subscription
Agreements") with certain institutional investors (the "Investors"), pursuant to
which Selina agreed to issue and sell, in private placements expected to close
concurrently with the closing of the Business Combination, $147,500,000
aggregate principal amount of unsecured convertible notes (the "Notes") for an
aggregate purchase price equal to 80.00% of the principal amount of the Notes
("Purchase Price"). The Notes will mature four years after their issuance.

As additional consideration for the Purchase Price, the Note Subscription
Agreements provide that each Investor will receive a warrant to purchase a
number of Selina Ordinary Shares equal to approximately one-third of the number
of Selina Ordinary Shares into which the principal amount of such Investor's
Note converts (the "Investor Warrants"). The Investor Warrants will be issued
pursuant to the terms of an Amended and Restated Warrant Agreement, to be
entered into by the Company, Selina and Continental Stock Transfer & Trust
Company concurrently with the closing of the Business Combination (the "A/R
Warrant Agreement"). The Investor Warrants have an exercise price of $11.50 per
share, subject to adjustment and are identical to our Public Warrants in all
other material respects, except (i) the Investor Warrants are not subject to
redemption and (ii) a holder of an Investor Warrant may exercise such Investor
Warrant on a cashless basis under the circumstances described in the A/R Warrant
Agreement. Upon transfer of the Investor Warrant, such Investor Warrant will
thereafter be redeemable by Selina and the holder of the Investor Warrant may no
longer exercise such Investor Warrant on a cashless basis.

Sponsor Letter Agreement



In connection with the execution of the Subscription Agreements, certain
Investors who subscribed for over $4,000,000 in principal amount of Notes also
entered into letter agreements (the "Sponsor Agreements") with the Sponsor,
pursuant to which the Sponsor agreed to transfer, at the closing of the Business
Combination, shares of our Class B common stock owned by the Sponsor (or Selina
Ordinary Shares exchange therefor) to such Investors (the "Sponsor Shares"). The
number of Sponsor Shares to be transferred to such Investors was determined by
multiplying an Investor's aggregate principal investment in the Notes by a
percent ranging from 2.5% to 7.5% based on the principal amount of the Notes for
which such Investor subscribed. The Sponsor Shares will be transferred from the
25% sponsor share pool established pursuant to the Sponsor Letter Agreement that
was entered into by the Company, the Sponsor, and Selina in connection with the
execution of the of the Business Combination Agreement.

                                       23

  Table of Contents

Results of Operations

We have neither engaged in any operations nor generated any revenues to date.
All activity from our inception through the date of our Public Offering,
February 26, 2021, was in preparation for our Public Offering. Since our Public
Offering, our activity has been limited to the evaluation of Business
Combination candidates. We do not expect to generate any operating revenues
until the closing and completion of our Business Combination. We expect to
generate non-operating income in the form of interest income on marketable
securities held after the Initial Public Offering. We incur increased expenses
as a result of being a public company (for legal, financial reporting,
accounting and auditing compliance), as well as for due diligence expenses.

Comparison of the three months ended June 30, 2022 versus the three months ended June 30, 2021



For the three months ended June 30, 2022, we had a net income of $1,536,557,
which was primarily due to a gain from the change in fair value of the
derivative warrant liabilities of $1,566,583, income tax expense of $9,130 and
interest earned on marketable securities held in Trust Account of $313,919. This
was partially offset by $284,817 in operating costs and $50,000 of franchise tax
expense.

For the three months ended June 30, 2021, we had a net income of $2,470,037, which was primarily due to a gain from the change in fair value of the derivative warrant liabilities of $2,666,342. This was partially offset by $149,778 in operating costs and $50,000 of franchise tax expense.

Comparison of the six months ended June 30, 2022 versus the six months ended June 30, 2021


For the six months ended June 30, 2022, we had a net income of $4,981,336, which
was primarily due to a gain from the change in fair value of the derivative
warrant liabilities of $5,473,241, income tax expense of $9,130 and interest
earned on marketable securities held in Trust Account of $317,317. This was
partially offset by $700,107 in operating costs and $100,000 of franchise tax
expense.

For the six months ended June 30, 2021, we had a net income of $1,089,679, which
was primarily due to a gain from the change in fair value of the derivative
warrant liabilities of $1,846,825. This was partially offset by $438,197 of
issuance costs attributed to the warrant liability, $222,422 in operating costs,
and $100,000 of franchise tax expense.

As described in Note 2, Summary of Significant Accounting Policies, in "Part 1.
Financial Information - Item 1. Financial Statements," we account for the
Warrants issued in connection with our Public Offering and Private Placement as
derivative instruments which were initially recorded at their fair value. These
derivative instruments are subject to remeasurement at each balance sheet date
until exercised, and any change in fair value is recognized in our statements of
operations.

Liquidity and Capital Resources

As of June 30, 2022, we had cash of $10,434 held outside the Trust Account. We intend to use the funds held outside the Trust Account primarily for due diligence fees and other expenses related to the Business Combination.



As of June 30, 2022, we had cash and marketable securities in the Trust Account
of $230,329,107. We intend to use substantially all of the funds held in the
Trust Account, including any amounts representing interest earned on the Trust
Account (less deferred underwriting commissions) to complete our initial
Business Combination.

Material cash requirements

As of June 30, 2022, we do not have any debt, lease obligations or other capital commitments.


The underwriters are entitled to deferred fee of 3.5% of the gross proceeds of
the Public Offering, or $8,050,000. The deferred fee will become payable to the
underwriters from the amounts held in the trust account solely in the event that
we complete our initial business combination.

                                       24

  Table of Contents

Sources of cash

Prior to the completion of the Public Offering, our liquidity needs were satisfied through receipt of $25,000 from the sale of founder shares to Bet on America LLC, or the "Sponsor."



On February 26, 2021, we consummated the Public Offering of 23,000,000 Units at
a price of $10.00 per unit generating net proceeds of $217,111,865. Transaction
costs were $12,888,135, including $4,600,000 of underwriting fees, $8,050,000 of
deferred underwriting fees and $238,135 of other offering costs in connection
with the Public Offering. Simultaneously with the closing of the Public
Offering, we consummated the sale of 6,575,000 Private Placement Warrants to our
Sponsor at a price of $1.00 per warrant, generating gross proceeds of
$6,575,000. Following the closing of the Public Offering and the sale of the
Private Placement Warrants, a total of $230,000,000 was placed in a Trust
Account and following the payment of certain transaction expenses.

Uses of cash

                                                                 Six Months Ended June 30,
                                                        2022             2021              Change
Net cash used in operating activities                $ (750,142)    $     (643,337)    $     (106,805)
Net cash used in investing activities                $         -    $ (230,000,000)    $   230,000,000
Net cash provided by financing activities            $         -    $   

231,736,865 $ (231,736,865)




For the six months ended June 30, 2022, cash used in operating activities was
$750,142. Net income of $4,981,336 was impacted by the non-cash changes in fair
value of the derivative warrant liability of $5,473,241, as well as the interest
earned on marketable securities held in Trust Account of $317,317. Additionally,
changes in operating assets and liabilities used $59,080 of cash used in
operating activities.

For the six months ended June 30, 2021, cash used in operating activities was
$643,337. Net income of $1,089,679 was adjusted for the interest earned on
marketable securities held in Trust Account of $3,473, the issuance costs
attributed to the warrant liabilities of $438,197, and the non-cash change in
fair value of the derivative warrant liabilities of $1,846,825. Additionally,
changes in operating assets and liabilities provided $320,915 of cash used in
operating activities.

In order to fund working capital deficiencies and/or finance transaction costs
in connection with an initial Business Combination, our Sponsor or an affiliate
of our Sponsor or certain of our officers and directors may, but are not
obligated to, loan us funds as may be required. If we complete our initial
Business Combination, we would repay such loaned amounts. In the event that our
initial Business Combination does not close, we may use a portion of the working
capital held outside the Trust Account to repay such loaned amounts but no
proceeds from our Trust Account would be used for such repayment. Up to
$1,500,000 of such loans may be convertible into warrants, at a price of $1.00
per warrant at the option of the lender. The warrants would be identical to the
Private Placement Warrants, including as to exercise price, exercisability and
exercise period.

As of June 30, 2022 and December 31, 2021, the Company had $10,434 and $760,576
in cash not held in the Trust Account and available for working capital
purposes, respectively. The Company believes it may need to raise additional
funds in order to meet the expenditures required for operating the business. If
the Company's estimate of the costs of identifying a target business,
undertaking in-depth due diligence and negotiating an initial Business
Combination are less than the actual amount necessary to do so, the Company may
have insufficient funds available to operate the business prior to the initial
Business Combination. Moreover, the Company may need to obtain additional
financing either to complete the initial Business Combination or to redeem a
significant number of our public shares upon completion of the initial Business
Combination, in which case the Company may issue additional securities or incur
debt in connection with such initial Business Combination. If the Company is
unable to complete the Business Combination because it does not have sufficient
funds available, the Company will be forced to cease operations and liquidate
the Trust Account.

In connection with the Company's assessment of going concern considerations in
accordance with Financial Accounting Standards Board's ("FASB") Accounting
Standards Codification ("ASC") Topic 205-40, Presentation of Financial
Statements-Going Concern, the Company has until February 26, 2023, to consummate
an initial business combination. It is uncertain that the Company will be able
to consummate an initial business combination by this time. If an initial
business combination is not consummated by this date, there will be a mandatory
liquidation and subsequent dissolution of the Company. Additionally, the Company
may not have sufficient liquidity to fund the working capital needs of the
Company through one year from the issuance of these financial statements.

                                       25

Table of Contents



Management has determined that the liquidity condition and mandatory liquidation
and potential subsequent dissolution raises substantial doubt about the
Company's ability to continue as a going concern. No adjustments have been made
to the carrying amounts of assets or liabilities should the Company be required
to liquidate after February 26, 2023. The Company's sponsor, officers and
directors may, but are not obligated to, loan the Company funds from time to
time or at any time, in whatever amount they deem reasonable in their sole
discretion, to meet the Company's working capital needs.

Critical Accounting Policies



Our management makes a number of significant estimates, assumptions and
judgments in the preparation of our financial statements. See Note 2, Summary of
Significant Accounting Policies, in "Part I. Financial Information - Item 1.
Financial Statements" for a discussion of the estimates and judgments necessary
in our accounting for derivative warrant liabilities, common stock subject to
possible redemption, and net income (loss) per common share. Any new accounting
policies or updates to existing accounting policies as a result of new
accounting pronouncements have been included in the notes to our condensed
financial statements contained in this Quarterly Report on Form 10-Q. The
application of our critical accounting policies may require management to make
judgments and estimates about the amounts reflected in the condensed financial
statements. Management uses historical experience and all available information
to make these estimates and judgments. Different amounts could be reported using
different assumptions and estimates.

Recent Accounting Pronouncements



Please refer to Note 2, Summary of Significant Accounting Policies, in "Part 1.
Financial Information - Item 1. Financial Statements" for a discussion of recent
accounting pronouncements and their anticipated effect on our business.

© Edgar Online, source Glimpses